The Centre for Cellular and Molecular Platforms (C‑CAMP), Bangalore and the California Institute for Quantitative Biosciences (QB3), a California-based non-profit research and technology commercialisation institute spanning three University of California (UC) campuses kickstarted the India Immersion Program for two start-ups from UC universities at the recently concluded BIRACBIG Conclave organised at C‑CAMP where they got an opportunity to interact with over 75 startups from India.
C‑CAMP Director and COO, Dr. Taslimarif Saiyed said, “We are delighted to have Dr. Derek Dashti, Founder D & P Innovations and Dr. Daniel Burnett, Co-founder Respirix with us. Both these entrepreneurs have technologies that have potential solutions for specific healthcare needs in India as well as significant market opportunity in India. D & P Innovations is a regenerative medicine startup focused on repairing damaged organs, is developing an implantable, bioresorbable medical device to functionally regenerate a damaged esophagus. Respirix is working on a non-invasive device that will bring the power of predictive analytics to the home healthcare setting with an initial target of revolutionising the care of congestive heart failure. ”
The 2 startups will spend up to 14 days in India understanding the local life science ecosystem. During their time here, they will meet with policy makers, investors, key opinion leaders in healthcare, successful entrepreneurs, and visit CROs, biotech companies, incubators and accelerators.
The India Immersion Award was made possible by the support of the Department of Biotechnology, Government of India and Centre for Innovation, Incubation and Entrepreneurship, CIIE. C‑CAMP is now initiating a US Immersion Program for its startups.